I want Raygun, the 36 year old Australian breakdancer possessed by the spirit of Julia Stiles in Save the Last Dance, to know that I am now her biggest fan and she should never stop doing whatever it is she’s trying to do

If you care about #pharmacare, read this by Matthew Herder & Steve Morgan, PhD. Their conclusion: sadly we're not getting what Dr. Eric Hoskins Advisory Council recommended. Bill needs to be amended. Pharmacare as laid out in Bill C64 doesn't give the benefits of...🧵 cmaj.ca/content/196/27…

Dr Raygun has achieved a feat absolutely unheard of in academia - people are reading her thesis

The first 10 drug price negotiations under the IRA are here: endpts.com/federal-govern…

Fair prices are here! 💊Savings are better than expected & no companies dropped out! 💊💊 All Part D enrollees get a better benefit, whether they take these drugs or not. 💊💊💊 Price reduction on cancer drug suggests plenty of incentive to innovate. cms.gov/files/document…

Check out our study 👇👇👇 cc: Vinay Prasad MD MPH Arianna Gentilini Alyson Haslam

"Cancer care should be firmly placed back at the top of the political agenda; doing this would save thousands of peoples' lives a year." Ajay Aggarwal Richard Sullivan Mark Lawler Julie Gralow

academia finally pays off Taylor Swift and philosophy LSE lse.ac.uk/Events/2024/10…

No truer words were ever said.

A lot of discussion about drug prices is abstract, but this is striking. This is a forecast sent out by Michael Yee at Jefferies for the GLP-1 drugs, forecasting sales of more than $120 billion. You'll notice 80% of the sales (that black line) are in the U.S. That's likely as

Super interesting comparative research published today in BMJ Oncology on the impact of COVID and Brexit in the UK Dr Mark Lythgoe

This JAMA Network Open study by Maryam Mooghali, MD, MSc Joseph Ross Joshua D. Wallach Reshma Ramachandran is a nice counterpoint to a recent Health Affairs podcast I listened to which gave the impression that Breakthrough Therapy designation is all upside jamanetwork.com/journals/jaman…

Don't discount the power of PR.... doi.org/10.1111/j.1548… Interesting to see what happens...

In nursing school, we were taught to call patients “clients” which was always a weird sign of the financialization of medicine

NEW! Our research in The Bulletin of the World Health Organization on the impacts of COVID-19 on health worker protests, drawing on ACLED data from 159 countries. Kartik Sharma Sorcha A Brophy Mike Law Health worker protests and the COVID-19 pandemic: an interrupted time-series analysis ncbi.nlm.nih.gov/pmc/articles/P…

Legacies of conflict and humanitarian crises on cancer care - The Lancet Oncology thelancet.com/journals/lanon…

In Clinical Oncology, Dr Mark Lythgoe and I comment on the state of supportive care in oncology. Metrics including drug approvals, global funding, and the number of ongoing clinical trials show a predominant focus on anti-cancer therapeutics over supportive care interventions.

New Job Alert Assistant, Associate, or Full Professors - Vanderbilt Department of Health Policy - Nashville, TN dlvr.it/TCwLdL

Trial Authors: Details are described in the Protocol available in the Supplementary Appendix. Supplementary Appendix: Read me if you can!